ViroGates A/S
VIRO.CO · CPH
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.25 | 0.00 | 0.17 | -0.07 |
| FCF Yield | -3.19% | 1.50% | -1.97% | -4.09% |
| EV / EBITDA | -36.34 | -17.34 | -16.05 | -16.35 |
| Quality | ||||
| ROIC | -23.88% | -30.53% | -19.16% | -26.71% |
| Gross Margin | 63.30% | 84.07% | 44.26% | 47.50% |
| Cash Conversion Ratio | 1.29 | -0.28 | 0.35 | 0.76 |
| Growth | ||||
| Revenue 3-Year CAGR | -13.96% | -6.87% | -19.69% | -23.60% |
| Free Cash Flow Growth | -374.75% | 192.36% | 70.70% | -156.78% |
| Safety | ||||
| Net Debt / EBITDA | 2.14 | 2.21 | 2.16 | 1.50 |
| Interest Coverage | -16.01 | -10.61 | -10.55 | -29.55 |
| Efficiency | ||||
| Inventory Turnover | 0.34 | 0.25 | 0.31 | 0.28 |
| Cash Conversion Cycle | 258.54 | 161.14 | 327.22 | 386.39 |